PATENT CLAIM ANALYSIS

Application Number: 15970403
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Provided herein are compositions and methods for the treatment of HCMV infection in a subject.

Claim (Index 23):
The antibody of  claim 16 , wherein the antibody is selected from the group consisting of:\n a full length immunoglobulin molecule; an scFv; a Fab fragment; an Fab\u2032 fragment; an F(ab\u2032)2; an Fv; a NANOBODY\u00ae; and a disulfide linked Fv.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13530891', '10897508', '13694280', '13887244', '15674569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7736740317761822
- 35 USC 102 Novelty (BERT): 0.5043151737485927
- Combined Prediction Score: 0.7467381459734233
- Mean Citation Score: 250.515348
- Max Citation Score: 261.94858
- Similarity Product: 180.87270519588108

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test